查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869858

經皮貼片市場規模、佔有率和趨勢分析報告：按類型、應用、分銷管道、地區和細分市場預測（2025-2030 年）

Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

經皮貼片市場摘要

預計到 2024 年，全球經皮貼片市場規模將達到 62 億美元，到 2030 年將達到 95.5 億美元。

預計從 2025 年到 2030 年，該市場將以 7.6% 的複合年成長率成長。成長要素包括心血管疾病、糖尿病和慢性疼痛等慢性疾病的增加，消費者對侵入性較小的治療方法的偏好日益成長，全球人口老化，以及經皮給藥技術的進步。

與口服或注射藥物相比，經皮貼片提供了一種非侵入性且便捷的給藥方式。這提高了患者按醫囑用藥的可能性，並減少了與口服藥物相比的胃腸道副作用。由於其使用方便且能長時間穩定釋放藥物，經皮貼片預計將擁有很高的需求，尤其是在慢性病管理方面。

由於全球慢性病發病率的上升，該行業正經歷顯著成長。截至2024年2月，美國美國1.29億人患有至少一種主要慢性病，包括癌症、心臟病、肥胖、糖尿病和高血壓。治療方法慢性疼痛最常見的方法是患者每日服用止痛藥，不僅繁瑣，而且口服和注射藥物往往副作用較大，且給藥頻率較低。經皮貼片在這種情況下非常有效，因為它們可以透過在較長時間內持續釋放藥物來提高患者的依從性。例如，Fentanyl經皮貼片已核准用於慢性疼痛管理，它透過在72小時內持續釋放Fentanyl，以較低的劑量緩解疼痛，從而減少給藥次數。

微針、離子導入和滲透促進劑等創新技術正在拓展經皮給藥領域，為大分子藥物和生物製藥的給藥開闢了新的途徑。微針貼片可在皮膚上形成微小通道，從而促進那些體積過大而無法經經皮給藥的大分子藥物的輸送。例如，載有胰島素的微針貼片為每日注射提供了一種無痛替代方案，並有助於最佳化血糖值控制。離子導入是一種更新、更具創新性的給藥策略，它利用微弱的電脈衝驅動藥物穿透皮膚。

目錄

第1章調查方法和範圍

第2章執行摘要

第三經皮透皮貼片市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章經皮貼片市場：類型估算與趨勢分析

  • 細分儀表板
  • 經皮貼片市場：按類型分類的差異分析（單位：十億美元），2018 年和 2030 年
  • 經皮貼片市場：產品展望
  • 2018年至2030年市場規模、預測與趨勢分析
  • 單層藥物內黏合劑
  • 多層藥物黏合劑
  • 矩陣
  • 其他類型

第5章經皮貼片市場：應用預測與趨勢分析

  • 細分儀表板
  • 經皮貼片市場：應用趨勢分析
  • 經皮貼片市場：功能展望
  • 2018年至2030年市場規模、預測與趨勢分析
  • 緩解疼痛
  • 減少吸菸和戒菸支持
  • 心血管疾病
  • 神經系統疾病
  • 荷爾蒙療法
  • 其他用途

第6章經皮貼片市場：通路預測與趨勢分析

  • 細分儀表板
  • 經皮貼片市場：通路波動分析
  • 經皮貼片市場：通路變化分析（單位：十億美元），2018 年和 2030 年
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章經皮貼片市場：區域估算與趨勢分析

  • 2024 年及 2030 年區域市佔率分析
  • 區域市場概覽
  • 全球區域市場概覽
  • 市場規模、預測趨勢分析（2018-2030）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業市佔率分析，2024 年
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Teikoku Pharma USA Inc.
    • Viatris Inc.
    • Johnson &Johnson
    • Luye Pharma Group
    • Purdue Pharma Manufacturing LP
    • Henan Lingrui Pharmaceutical Ltd
    • Samyang Biopharmaceuticals Corp.
    • Hisamitsu Pharmaceutical Co, Inc.
Product Code: GVR-4-68040-361-1

Transdermal Skin Patches Market Summary

The global transdermal skin patches market size was valued at USD 6.20 billion in 2024 and is projected to reach USD 9.55 billion by 2030, growing at a CAGR of 7.6% from 2025 to 2030. The market is increasing due to the growing incidence of chronic diseases such as cardiovascular disease, diabetes, chronic pain, etc., the enhanced preference of consumers for less-invasive treatment options, an aging population worldwide, and the technological advancement in transdermal drug delivery methods.

Transdermal patches offer a non-invasive and convenient approach to managing drugs through oral and injectable formulations; therefore, patients are more likely to take their medications as prescribed and experience lower gastrointestinal side effects than oral medications. Due to their ease of use and consistent drug-release rates over long periods, transdermal patches are especially appealing in chronic disease state management.

The industry is experiencing notable growth because of the rise of chronic diseases across the globe. In February 2024, the Centers for Disease Control and Prevention (CDC) estimates there are 129 million people in the United States with at least one key chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. The most common treatment for chronic pain is to have the patient take pain relief medication daily, which is not only tedious, but oral or injectable forms often have bothersome side effects and burdensome frequency of administration. Transdermal patches can show efficacy in these scenarios as they improve adherence to medication therapy through regulated medication delivery over a longer period. For example, fentanyl transdermal patches have been approved for chronic pain management and will continuously release fentanyl over 72 hours, providing low-dose relief and reducing the frequency of administration.

Innovations like microneedles, iontophoresis, and permeation enhancers have broadened the transdermal drug delivery landscape, creating new possibilities for administering large molecules and biologics. Microneedle patches generate tiny channels to the skin to enhance the delivery of large-molecule drugs that are too large to administer transdermally. For instance, a microneedle patch containing insulin allows for a pain-free way of taking insulin rather than daily needles, which may optimize control of glycemic levels. Iontophoresis is a newer, innovative delivery strategy that utilizes a small electric charge to help push drugs through the skin.

Global Transdermal Skin Patches Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and analyzes the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global transdermal skin patches market report by type, application, distribution channel, and region:

  • Type Outlook (Revenue, USD Unit, 2018 - 2030)
  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Other Types
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Cardiovascular Disorders
  • Neurological Disorders
  • Hormonal Therapy
  • Other Applications
  • Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in the Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic diseases
      • 3.2.1.2. Increased consumer preference for minimally invasive treatment
      • 3.2.1.3. Aging global population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Skin irritation and allergic reactions
      • 3.2.2.2. Limited awareness
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic landscape
      • 3.2.4.3. Social landscape
      • 3.2.4.4. Technological landscape
      • 3.2.4.5. Environmental landscape
      • 3.2.4.6. Legal landscape

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transdermal Skin Patches Market: Type Movement Analysis, USD Billion, 2018 & 2030
  • 4.3. Transdermal Skin Patches Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Single-layer Drug-in-Adhesive
    • 4.5.1. Single-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Multi-layer Drug-in-Adhesive
    • 4.6.1. Multi-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Matrix
    • 4.7.1. Matrix Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 4.8. Other Types
    • 4.8.1. Other Types Market Estimates And Forecasts, 2018 to 2030(USD Billion)

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transdermal Skin Patches Market: Application Movement Analysis
  • 5.3. Transdermal Skin Patches Market by Function Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Pain Relief
    • 5.5.1. Pain Relief Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 5.6. Smoking Reduction and Cessation Aid
    • 5.6.1. Smoking Reduction Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 5.7. Cardiovascular Disorders
    • 5.7.1. Cardiovascular Disorders Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 5.8. Neurological Disorders
    • 5.8.1. Neurological Disorders Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 5.9. Hormonal Therapy
    • 5.9.1. Hormonal Therapy Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 5.10. Other Applications
    • 5.10.1. Other Applications Market Estimates And Forecasts, 2018 to 2030(USD Billion)

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transdermal Skin Patches Market: Distribution Channel Movement Analysis
  • 6.3. Transdermal Skin Patches Market: Distribution Channel Movement Analysis, USD Billion, 2018 & 2030
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market Estimates And Forecasts, 2018 to 2030(USD Billion)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market Estimates And Forecasts, 2018 to 2030(USD Billion)

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Transdermal Skin Patches Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. Teva Pharmaceutical Industries Ltd
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Novartis AG
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Teikoku Pharma USA Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Viatris Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Luye Pharma Group
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Purdue Pharma Manufacturing LP
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Henan Lingrui Pharmaceutical Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Samyang Biopharmaceuticals Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Hisamitsu Pharmaceutical Co, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness the Highest Growth
  • Table 4 Global Transdermal Skin Patches Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 Global Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8 North America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 North America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 11 North America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Canada Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Canada Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 20 Mexico Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21 Europe Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 22 Europe Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Europe Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Europe Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25 UK Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 UK Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 UK Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 Germany Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 29 Germany Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 Germany Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31 France Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 France Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 33 France Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Italy Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 Italy Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 Italy Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37 Spain Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Denmark Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 41 Denmark Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 42 Denmark Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43 Sweden Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 44 Sweden Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Sweden Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 Norway Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 Norway Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 Norway Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 Japan Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 54 Japan Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Japan Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56 China Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 China Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 China Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59 India Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 60 India Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 61 India Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62 South Korea Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 South Korea Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 South Korea Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 Australia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 66 Australia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 67 Australia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68 Thailand Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 69 Thailand Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 70 Thailand Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71 Latin America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 72 Latin America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 73 Latin America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 74 Latin America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75 Brazil Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 76 Brazil Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Brazil Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78 Argentina Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 79 Argentina Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 80 Argentina Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Middle East and Africa Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 82 Middle East and Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 Middle East and Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 84 Middle East & Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85 South Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 86 South Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 87 South Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 90 Saudi Arabia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91 UAE Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 92 UAE Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 93 UAE Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 96 Kuwait Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market segment scope and definition
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Transdermal Skin Patches market: Type movement analysis
  • Fig. 17 Transdermal Skin Patches market: Type segment dashboard
  • Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
  • Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Multi-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Matrix Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Other Types Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Transdermal Skin Patches market: Application movement analysis
  • Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
  • Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
  • Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 67 List of key emerging companies/indication disruptors/innovators